0001950047-24-002743.txt : 20240328 0001950047-24-002743.hdr.sgml : 20240328 20240328163810 ACCESSION NUMBER: 0001950047-24-002743 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240328 DATE AS OF CHANGE: 20240328 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Stoke Therapeutics, Inc. CENTRAL INDEX KEY: 0001623526 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 471144582 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38938 FILM NUMBER: 24799778 BUSINESS ADDRESS: STREET 1: 45 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 BUSINESS PHONE: 781-430-8200 MAIL ADDRESS: STREET 1: 45 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 FORMER COMPANY: FORMER CONFORMED NAME: ASOthera Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20141028 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Allan Jonathan CENTRAL INDEX KEY: 0001966716 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O STOKE THERAPEUTICS, INC. STREET 2: 45 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 144 1 primary_doc.xml 144 0001966716 XXXXXXXX LIVE 0001623526 STOKE THERAPEUTICS INC 001-38938 45 Wiggins Ave Bedford MA 01730 7814308200 JONATHAN ALLAN Officer COMMON Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 8th Floor New York NY 10004

5126 72635.42 46303743 03/28/2024 NASDAQ Common 03/15/2024 Restricted Stock Units Issuer N 5126 03/15/2024 N/A Y 03/28/2024 12/15/2023 /s/ Jonathan Allan